Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
ARTICLE

Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos

Jin H. Son, Hong S. Chun, Tong H. Joh, Sunghee Cho, Bruno Conti and Jong W. Lee
Journal of Neuroscience 1 January 1999, 19 (1) 10-20; https://doi.org/10.1523/JNEUROSCI.19-01-00010.1999
Jin H. Son
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong S. Chun
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tong H. Joh
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunghee Cho
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Conti
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jong W. Lee
1Department of Neurology and Neuroscience, Cornell University Medical College and Laboratory of Molecular Neurobiology, The W. M. Burke Medical Research Institute, White Plains, New York 10605
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    The TH9.0 kb-SV40TagA58 hybrid gene and its tissue-specific expression in DA neurons of the transgenic mouse SN.A, Diagram of the TH9.0-SV40Tag-tsA58 DNA construct containing 9.0 kb of rat TH 5′ promoter region, the transcription initiation site (dashed lines), and 27 bp of 5′ untranslated region fused to a 2.7 kbBglI/BamHI fragment of SV40-Tag-tsA58. The resulting 11.7 kb of fusion gene was isolated from the plasmid vector and used to generate two transgenic founders, TA58-#8 and TA58-#13. The locations of primers for PCR are marked by black squares. Bm denotes the restriction enzyme sites for BamHI. B, Line TA58-#8 expressed the SV40Tag-A58 in DA neurons of the SN as demonstrated by SV40Tag immunostaining. C, TH immunostaining in the adjacent coronal SN sections. The DA neurons are specifically immunostained by both antibodies. Because of the nuclear localization of SV40Tag, the monoclonal SV40Tag antibody did not stain TH-positive fibers, and the intensity of SV40Tag immunostaining was not as strong as TH immunostaining in brain tissue sections.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    TH and SV40Tag immunostaining of SN DA cell line SN4741. For the establishment of DA cell lines, mesencephalic SN regions from E13.5 embryos from TA58-#8 were surgically removed under sterile conditions. The collected SN tissues were dissociated and cultured at 33°C with 5% CO2 in RF medium. The dispersed primary neuronal cell lines from the transgenic embryos were grown through repeated passages for 3–4 months to establish a pure cell population. The clonal origin of a colony was monitored and confirmed by microscopic observation during its colony formation.A, The morphology of an early SN DA cell colony (arrow) named SN-47. After the third cloning step, the DA cell line became morphologically flatter compared with the early clones. A representative SN DA cell line SN4741 was immunostained with TH polyclonal antibody (B) and more intensely with SV40Tag monoclonal antibody (C), respectively. The TH antibody stained the cytoplasm, whereas SV40Tag antibody stained exclusively the nucleus. Scale bars: B,C, 100 μm.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Detection of TH expression and DA neuronal markers by Western blot analysis and RT-PCR. A, The representative DA marker, TH expression, was confirmed by Western blot analysis after maintaining the SN4741 cells for a week in high-density culture at 37°C (lane 4) and 33°C (lane 5). The 62 kDa TH band in the SN4741 cells was consistent with the molecular weight of TH isolated from mouse adrenal gland (lane 1) and similarly derived locus coeruleus noradrenergic cell line, grown at 37°C (lane 2) and 33°C (lane 3), which were used as positive controls for the Western blot analysis. Each lane contained 15 μg of protein except lane 1 (5 μg) and lane 2 (30 μg). The specific amount of TH protein in the SN4741 cells grown at 37°C was higher than the culture at 33°C. As demonstrated in a TH-positive pheochromocytoma cell, PC12, culture (Kim et al., 1995), our SN DA cell line also exhibited the increase in TH expression in the high cell density during a prolonged culture (7–10 d). B, The expression of some DA neuron-specific markers, such as NT-3, BDNF, DA-T, and D2R were detected by RT-PCR in the SN4741 cell line. After Southern blotting of both 1 and 5 μl of each RT-PCR sample, the presence of each specific size band (the strongest band) was detected and confirmed with radiolabeled human BDNF cDNA, rat NT-3 cDNA, mouse DA-T cDNA, or mouse D2R oligonucleotide probe, respectively. Each filter was hybridized with each specific probe and exposed separately. The expected major band sizes were 430 bp for NT-3, 407 bp for BDNF, 553 bp for DA-T, and 490 bp for D2R. β represents the β-actin PCR product of 289 bp as an internal standard.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Morphological and phenotypic differentiation of the SN DA cell line SN4741 under various culture conditions. The morphological differentiation of the SN4741 cells was induced by culturing at the nonpermissive temperature (39°C) with a minimal serum concentration and/or retinoic acid. A, When grown at 33°C, the SN4741 cells have a fibroblast-like flat morphology with less prominent neurite growth. B, Under differentiation condition (i.e., nonpermissive temperature 39°C and reduction of FCS to 0.5%), the SN4741 cell line ceased proliferation and, after 2 d, started to display a neuronal morphology with extensive neurite outgrowth and, after 4 d, long bipolar or multipolar processes.C, Retinoic acid caused much longer and bipolar neurite extensions at 39°C. In contrast to the control SN4741 culture (D), the TH immunoreactivity of most SN4741 cell lines was greatly enhanced in the presence of the mesencephalic culture (E). In the coculture slides, the SN4741 cells can be distinguished from the primary DA neurons by their distinct morphology and size. The primary DA neurons (arrow) were morphologically multipolar or bipolar and much smaller than the SN4741 cells. F, MAP2 expression became consistently higher in the presence of retinoic acid at 39°C. Scale bars:A–C, 280 μm;D–F, 140 μm.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    BDNF protected the SN4741 cell line against various neurotoxic stresses. To measure BDNF-mediated neuroprotection against MPP+-, SNP-, glutamate-, or dopamine-mediated neurotoxicity, the SN4741 cells were pretreated with BDNF (50 ng/ml) for 10 min (open bars) and exposed to either 10 μm MPP+ for 15 hr, 0.5 mm glutamate for 10 min, 0.5 mm SNP for 5 min, or 5–15 nm dopamine for 18 hr in the presence of BDNF (open bars). Solid bars represents each control group. BDNF protected against MPP+-, glutamate-, or NO-induced neurotoxicity, but not against dopamine-induced neurotoxicity. All values are the mean ± SEM; *p < 0.05.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    BDNF but not NGF protects against MPP+-induced neurotoxicity. The neuroprotective functions of BDNF were further tested in comparison with NGF against MPP+-induced neurotoxicity in the SN DA cell culture. Only BDNF exerted its neuroprotective function against MPP+-neurotoxicity. All values are the mean ± SEM; *p < 0.05.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    BDNF secretion from the SN DA cell line under normal and stress conditions. The five representative classes of known neurotoxic insults, such as mitochondrial electron transport inhibitor (MPP+), free radical generator (H2O2), NO producer (SNP), excitatory amino acid (glutamate), and proinflammatory cytokine (TNF-α) were tested. After treatment with sublethal doses of MPP+(5 μm), SNP (0.05 mm), H2O2 (0.05 mm), glutamate (0.1 mm), or TNF-α (50 ng/ml), the amount of BDNF in the cell-conditioned medium was quantified by ELISA. Glutamate and TNF-α increased the release of BDNF by 30–50%. Of interest, two potential free radical generators, NO (SNP) and H2O2, but not MPP+, significantly suppressed the amount of BDNF release by ∼30–40%. All values are the mean ± SEM; *p < 0.05.

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Tyrosine phosphorylation of TrkB by BDNF treatment. A, The presence of TrkB in SN4741 cell line was demonstrated by Western blot analysis using TrkB antibody. The first lane (RF) contains the SN4741 cell lysate grown in RF medium for 2 d, and the second lane (BDNF) contains the SN4741 cell lysate grown in RF medium containing BDNF (50 ng/ml) for 24 hr. Total mouse brain extract (BRAIN) was used as a positive source of TrkB protein and A431 cell extract (431) as a negative control as the supplier suggested. B, The exogenous BDNF treatment (BDNF) for 24 hr led to a significant increase of tyrosine phosphorylation of TrkB compared with the nontreated TrkB expressing SN4741 cell line (RF), as detected by Western blot using the p-Tyr antibody. The first lane (RF) contains the SN4741 lysate grown in RF medium for 48 hr, and the second lane (BDNF) includes the cell lysate grown in RF medium containing BDNF (50 ng/ml) for 24 hr. A basal level of TrkB activation (RF), without the exogenous BDNF, was consistently observed at >60–70% confluence, in which the activation of TrkB could be induced by the secreted BDNF. Total mouse brain extract (BRAIN) was used as a positive source of the activated TrkB protein and A431 cell extract (431) as a negative control.

Tables

  • Figures
    • View popup
    Table 1.

    Comparison of the expression of various DA neuronal markers under permissive (33°C) and nonpermissive temperature (39°C) in the SN4741 cells

    Markers33°C39°C
    TH++
    AADC++
    GTPCH++++
    NF-M+++
    NSE++
    MAP1+++
    MAP2+++++
    Synaptophysin++
    SV40 Tag++++
    BDNF+++
    NT-3+++
    TrkB++
    D2R++
    DA-T+++
    • The expression of general neuronal markers, such as NSE, MAP1, MAP2, NF-M, and synaptophysin, and specific DA neuronal markers, such as TH, AADC, and GTPCH, were determined by immunocytochemistry. The expression of DA-T, D2R, BDNF, and NT-3 were semiquantitated by RT-PCR. DA-T was also determined by dopamine uptake. TH and TrkB expressions were confirmed by Western blot analysis. Note: +, low; ++, medium; +++, high.

Back to top

In this issue

The Journal of Neuroscience: 19 (1)
Journal of Neuroscience
Vol. 19, Issue 1
1 Jan 1999
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos
Jin H. Son, Hong S. Chun, Tong H. Joh, Sunghee Cho, Bruno Conti, Jong W. Lee
Journal of Neuroscience 1 January 1999, 19 (1) 10-20; DOI: 10.1523/JNEUROSCI.19-01-00010.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos
Jin H. Son, Hong S. Chun, Tong H. Joh, Sunghee Cho, Bruno Conti, Jong W. Lee
Journal of Neuroscience 1 January 1999, 19 (1) 10-20; DOI: 10.1523/JNEUROSCI.19-01-00010.1999
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • neuroprotection
  • bdnf
  • substantia nigra
  • dopaminergic neuron
  • Parkinson’s disease
  • transgenic mice
  • neuronal differentiation
  • conditional immortalization

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Calcium Influx via L- and N-Type Calcium Channels Activates a Transient Large-Conductance Ca2+-Activated K+Current in Mouse Neocortical Pyramidal Neurons
  • Netrin-1 Is a Chemorepellent for Oligodendrocyte Precursor Cells in the Embryonic Spinal Cord
  • Selective Enhancement of Synaptic Inhibition by Hypocretin (Orexin) in Rat Vagal Motor Neurons: Implications for Autonomic Regulation
Show more ARTICLE
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.